A bioavailability study on three oral preparations of the combination trimethoprim-sulfamethoxazole.
D000284:Administration, Oral; D000328:Adult; D000704:Analysis of Variance; D000890:Anti-Infective Agents / Q000378:metabolism*; D001702:Biopharmaceutics; D001835:Body Weight; D002214:Capsules; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005493:Folic Acid Antagonists / Q000378:metabolism*; D006801:Humans; D008297:Male; D011743:Pyrimidines / Q000378:metabolism*; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000378:metabolism*; D013535:Suspensions; D013607:Tablets; D013997:Time Factors; D014295:Trimethoprim / Q000008:administration & dosage / Q000378:metabolism
D000890:Anti-Infective Agents; D002214:Capsules; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013535:Suspensions; D013607:Tablets; D014295:Trimethoprim; D013420:Sulfamethoxazole